The significant growth in the value of Regeneron Pharmaceuticals stock over the past two decades highlights the company's strong performance and its ability to outperform the market. This historical performance, coupled with a substantial market capitalization, suggests a positive outlook for the stock in the short term, as it demonstrates the company's resilience and potential for continued growth.